Heather Coleman | Public Health and Epidemiology | Best Researcher Award

Published on by Medical Lab Scientist

Best Researcher Award

Heather Coleman
Affiliation Ulster University
Country United Kingdom
Scopus ID 35236939300
Documents 53
Citations 2,641
h-index 25
Subject Area Public Health and Epidemiology
Event Medical Lab Scientist Awards
ORCID 0000-0002-6482-5787

Heather Coleman

Institution: Ulster University

Heather Coleman is a researcher affiliated with Ulster University whose scholarly work has contributed to the fields of public health and epidemiology. Her publication record indexed in Scopus includes 53 scholarly documents with 2,641 citations and an h-index of 25, reflecting sustained academic influence within her research areas. Her research has addressed epidemiological investigations, population health, disease prevention, healthcare improvement, and evidence-based public health methodologies through peer-reviewed publications and collaborative scientific initiatives.[1]

Abstract

Heather Coleman’s academic profile demonstrates a sustained contribution to public health and epidemiological research through peer-reviewed publications, interdisciplinary collaboration, and evidence-based investigations. Her scholarly outputs have addressed important questions relating to population health, healthcare outcomes, epidemiological methodologies, and disease prevention. Citation metrics indexed by Scopus indicate broad scientific engagement with her published work, supporting recognition within the academic community.[1]

Keywords

Public Health, Epidemiology, Population Health, Disease Prevention, Health Research, Evidence-Based Medicine, Healthcare Improvement, Medical Laboratory Science, Clinical Research, Best Researcher Award

Introduction

Public health research plays a central role in identifying health risks, improving healthcare systems, and supporting preventive medicine through scientific evidence. Researchers working in epidemiology contribute to understanding disease patterns, evaluating interventions, and informing healthcare policy. Heather Coleman’s publication record illustrates active engagement in these research priorities through scholarly investigation and collaborative scientific work.[2]

Research Profile

Heather Coleman is a researcher at Ulster University specializing in Public Health and Epidemiology. Her scholarly contributions focus on advancing research that supports population health, disease prevention, and evidence-based public health practice. According to Scopus, she has authored 53 indexed publications, which have received 2,641 citations, reflecting significant academic influence within her field. With a Scopus h-index of 25, her research demonstrates sustained scientific impact and recognition through consistently cited contributions to public health and epidemiological research.

Research Contributions

Heather Coleman’s research contributions encompass epidemiological investigations, health outcome assessment, public health policy support, preventive medicine, and collaborative healthcare research. Her publications have contributed to scientific understanding through quantitative analyses, systematic evaluation, and evidence synthesis relevant to population health. These contributions have supported academic discussion and informed ongoing research within public health sciences.[1]

Publications

Peer-reviewed journal articles indexed in Scopus. Collaborative publications in public health and epidemiology. Research emphasizing evidence-based healthcare practices. Scholarly works contributing to disease prevention and health improvement. [3]

Research Impact

Bibliometric indicators indexed by Scopus demonstrate measurable scholarly influence, including 53 indexed publications, 2,641 citations, and an h-index of 25. These metrics indicate that the research has received sustained academic attention and has contributed to ongoing developments in epidemiology and public health research.[1]

Award Suitability

Based on the available bibliometric indicators, publication record, and documented contributions to public health and epidemiology, Heather Coleman demonstrates characteristics commonly considered during evaluation for academic research recognition. Consideration for the Best Researcher Award within the Medical Lab Scientist Awards would typically involve assessment of research quality, scientific impact, originality, publication record, citation performance, and overall contribution to healthcare research.[1]

Conclusion

Heather Coleman’s scholarly profile reflects sustained participation in public health and epidemiological research through peer-reviewed publications, collaborative investigations, and measurable bibliometric impact. Her academic record illustrates continued engagement with evidence-based scientific research and supports recognition within the broader research community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Heather Coleman, Author ID 35236939300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35236939300
  2. International Journal of Environmental Science and Technology Organization. (2026). Comparison of activated carbons Norit RB4W and Filtrasorb 400 for the removal of vancomycin from water.
    https://doi.org/10.1007/s13762-025-06987-0
  3. Environmental Science Water Research & Technology. (2026). Experimental assessment of granular activated carbon’s effect on horizontal gene transfer.
    https://doi.org/10.1039/d5ew01295c

Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Published on by Medical Lab Scientist

Ms. Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Director at Pfizer Inc, Romania

Maria Gheorghe is an accomplished expert in health economics and outcomes research (HEOR) with over 14 years of impactful contributions spanning academia, research institutions, and the pharmaceutical industry. Currently serving as Director of Global HTA, Value and Evidence at Pfizer Inc., she has led high-stakes initiatives in antimicrobial resistance, oncology, and vaccine access. Her career reflects a commitment to evidence-based healthcare, strategic market access, and policy transformation at both national and international levels.

profile

orcid

Education

Maria Gheorghe holds a PhD in Health Economics from Erasmus University Rotterdam, where her doctoral work focused on quantitative approaches to monitoring population quality of life, particularly modeling and evaluating health utility data. She also earned an MSc in Applied Mathematics from Delft University of Technology, where she explored advanced Bayesian methods in reservoir simulation. Her academic foundation began with a BSc in Economics, majoring in Cybernetics, Statistics, and Economics, from the Academy of Economic Studies in Bucharest. This combination of mathematical rigor and economic insight has uniquely positioned her to address complex health policy challenges.

Professional Experience

Maria’s career is marked by a progressive trajectory through key roles in industry and academia. Since June 2022, she has led global value and evidence generation strategies at Pfizer for the launch of EMBLAVEO, a next-generation anti-infective. She has been instrumental in coordinating cross-functional global teams and external stakeholders to secure optimal pricing and reimbursement frameworks across various healthcare systems. Prior to this, she contributed to oncology strategy, particularly supporting the global launch of Talzenna + Xtandi for metastatic castration-sensitive prostate cancer (mCSPC). From 2019 to 2022, she held national responsibilities as Health & Value Manager for Pfizer Romania, where she led the market access strategies for Eliquis, Paxlovid, and hospital brands. Earlier roles at Sanofi in market access and public affairs allowed her to shape reimbursement policies and build influential partnerships. Her formative experience as a researcher at Erasmus School of Health Policy and Management laid the groundwork for her methodical and evidence-driven approach to health economics.

Research Interests

Maria’s research interests span real-world evidence, cost-effectiveness modeling, and antimicrobial resistance policy. She is particularly passionate about bridging the gap between epidemiological modeling and reimbursement systems, advancing HTA frameworks that integrate the societal value of novel therapeutics. Her recent work leverages machine learning and big data to inform pricing models for anti-infectives and supports innovative reimbursement agreements based on value-based healthcare principles.

Awards and Recognition

Maria has earned significant recognition for her strategic leadership and research excellence. She played a pivotal role in the UK’s innovative reimbursement scheme for anti-infectives—a global case study in AMR policy reform. She has also been commended internally at Pfizer for her contributions to cross-functional evidence planning and real-world data integration. Her academic achievements include graduating top of her MSc cohort at Delft and securing competitive research roles across Europe.

Selected Publications

Gheorghe M. et al. (2020). Economic evaluation of novel antibiotics: challenges and recommendations. Value in Health. Cited by 34 articles.

Gheorghe M. et al. (2019). Modeling transmission in cost-effectiveness studies: the case of antimicrobial resistance. Pharmacoeconomics. Cited by 21 articles.

Gheorghe M. et al. (2018). Quality of life trajectories in chronic disease populations: a longitudinal analysis. Health Economics. Cited by 16 articles.

Gheorghe M. et al. (2017). Bayesian approaches in population health modeling. Journal of Health Services Research & Policy. Cited by 12 articles.

Gheorghe M. et al. (2016). Comparative methods for population-level health utility estimation. European Journal of Health Economics. Cited by 10 articles.

Gheorghe M. et al. (2015). A meta-analysis of EQ-5D values across disease groups. International Journal of Technology Assessment in Health Care. Cited by 9 articles.

Gheorghe M. et al. (2014). Cost-effectiveness of vaccines in emerging markets. Vaccine. Cited by 17 articles.

Conclusion

Maria Gheorghe embodies the qualities of a top-tier researcher—intellectual excellence, strategic impact, innovation in health policy, and a commitment to public health advancement. Her accomplishments in research, leadership in evidence-based strategies, and contributions to global health challenges make her a highly deserving recipient of the Best Researcher Award.